Indian spices for healthy heart - an overview

Current Cardiology Reviews

Volumn 6, Issue 4, 2010, Pages 274-279

  Vasanthi, Hannah R ^a   Parameswari, R P ^a  

^a SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Anti hypercholesterolemia; Anti inflammatory; Anti proliferative; Cardiovascular disease; Diabetes; Spices

Indexed keywords

ANTIOXIDANT; BLACK PEPPER EXTRACT; CINNAMON EXTRACT; CORIANDRUM SATIVUM EXTRACT; CURCUMIN; GARLIC EXTRACT; GINGER EXTRACT; PLACEBO; VANADIUM;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTHRITIS; ARTICLE; ATHEROSCLEROSIS; BLACK PEPPER; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CINNAMON; CONSTIPATION; CONTROLLED CLINICAL TRIAL (TOPIC); CORONARY ARTERY DISEASE; DEMENTIA; DIABETIC HYPERTENSION; FEVER; FLAVOR; GARLIC; GINGER; HEART; HEART DISEASE; HELMINTHIASIS; HUMAN; INDIA; INDIGESTION; INFECTION; KITCHEN; MUSCLE CRAMP; MYALGIA; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; RHEUMATIC DISEASE; SORE THROAT; SPICE; SPRAIN; TASTE; TRADITIONAL MEDICINE; VOMITING;

EID: 78651309482     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340310793566172     Document Type: Article

References (65)

1. USC-UCLA Joint East Asian Studies Center. Along the Silk Road, people, interaction & cultural exchange. http,//www.isop.ucla.edu/eas/suminst/links/silkunit.htm, 1993.
2. Silk Road Study Group. Silk road. http,//gallery.sjsu.edu/silkroad/info.htm, 2000.
3. Parry JW. The Story of Spices; Chemical Publishing Co: NewYork, 1953.
4. McCormick. The history of Spices. Available from: http://www.mccormick.com/content.cfm, 2006.
5. Ali SS, Kasoju N, Luthra A, Singh A, Sharanabasav H, Sahu A, Bora U. Indian medicinal herbs as sources of antioxidants. Food InternJ 2008; 41: 1-15.
6. Blumenthal M. The Complete German Commission E Monographs, Therapeutic Guide to Herbal Medicines; American BotanicalCouncil: Austin (Tex), 1998.
7. Frishman HW, Sinatra TS, Moizuddin M. The use of herbs fortreating cardiovascular disease. Semin Integr Med 2004; 2: 23-35.
8. Srivastava KC, Bordia A, Verma SK. Curcumin, a major componentof food spice turmeric (curcuma longa) inhibits aggregationand alters eicosanoid metabolism in human blood platelets. ProstaglandinsLeukot Essent Fatty Acids 1995; 52: 223-227.
9. Muthulakshmi V, Vijayakumar V, Vasanthkumar M, Vasanthi HR. Functional Foods for Chronic Diseases; Danik M. Martirosyan, Ed. D & A Inc/FF Publishing 2009; Vol. 4: pp. 274-317.
10. Stavric B. Role of chemopreventers in human diet. Clin Biochem 1994; 27: 319-332.
11. Rahman K. Historical perspective on garlic and cardiovasculardisease. J Nutr 2001; 131: 977-979.
12. Fenwick GR, Hanley AB. The genus Allium. Crit Rev Food SciNutr 1985; 22: 199-271.
13. Mykolas A. Functional foods for chronic diseases. Danik M. Martirosyan, Ed. D & A Inc/FF Publishing, 2009; Vol. 4: pp. 234-241.
14. Rahman K, Lowe GM. Garlic and cardiovascular disease, a criticalreview. J Nutr 2006; 136: 736-740.
15. Abramovitz D, Gavri S, Harats D, Levkovitz H, Mirelman D, Miron T, Eilat-Adar S, Rabinkov A, Wilchek M, Eldar M, Vered Z. Allicin-induced decrease in formation of fatty streaks (atherosclerosis)in mice fed a cholesterol-rich diet. Coron Artery Dis 1999; 10: 515-519.
16. Kleijnen J, Knipschild P, Terriet G. Garlic onions and cardiovascularrisk factors. A review of the evidence from human experimentswith emphasis on commercially available preparations. Br J ClinPharmacol 1989; 28: 535-544.
17. Yu-Yan Y, Liu L. Cholesterol lowering effect of garlic extracts andorganosulfur compounds, Human and animal studies. J Nutr 2001; 131: 989-993.
18. Gebhardt R, Beck H. Differential inhibitory effects of garlicderivedorganosulfur compounds on cholesterol biosynthesis inprimary rat hepatocyte culture. Lipids 1996; 31: 1269-1276.
19. Tapsell LC, Hemphill I, Cobiac L, Patch CS, Sullivan DR, Fenech M, Roodenrys S, Keogh JB, Clifton PM, Williams PG, Fazio VA, Inge KE. Health benefits of herbs and spices, the past, the present, the future. Med J Aust 2006; 185: 4-24.
20. Warshafsky S, Kamer RS, Sivak SK. Effect of garlic on total serumcholesterol, a Meta - analysis. Ann Int Med 1993; 119: 599-605.
21. Ebadi M. The Pharmacodynamic Basis of Herbal Medicine; CRCPress: BocaRaton 2002.
22. Banerjee SK, Maulik SK. Effect of garlic on cardiovascular disorders, a review. J Nutr 2002; 1: 1-14.
23. Kaye AD, De Witt BJ, Anwar M, Smith DE, Feng CJ, Kadowitz PJ, Nossaman BD. Analysis of responses of garlic derivatives inthe pulmonary vascular bed of the rat. J Appl Physiol 2000; 89: 353-358.
24. Mukherjee S, Lekli I, Goswami S, Das KD. Freshly C rushed garlicis a superior cardioprotective agent than processed garlic. J AgricFood Chem 2009; 57: 7137-7144.
25. Aggarwal BB, Sundaram C, Nikita M, Ichikawa H. Curcumin, theindian solid gold. Adv Exp Med Biol 2007; 595: 1-75.
26. Krishnaswamy K. Turmeric-The Salt of the Orient is the Spice of Life; Allied Publishers Pvt. Ltd.: New Delhi, India 2006.
27. Suryanarayana P, Saraswat M, Mrudula T, Krishna TP, Krishnaswamy K, Reddy GB. Curcumin and turmeric delay streptozotocininduceddiabetic cataract in rats. Invest Ophthalmol Vis Sci 2005; 46: 2092-2099.
28. Venkatesan N. Curcumin attenuation of acute adriamycin myocardialtoxicity in rats. Br J Pharmacol 1998; 124: 425-427.
29. Daosukho C, Chen Y, Noel T, Sompol P, Nithipongvanitch R, Velez MJ, Oberley DT, St. Clair KD. Phenylbutyrate, a histonedeacetylase inhibitor, protects against adriamycin-induced cardiacinjury. Free Radic Biol Med 2007; 42: 1818-1825.
30. Srivastava R, Dikshit M, Srimal RC, Dhawan BN. Anti-thromboticeffect of curcumin. Thromb Res 1985; 40: 413-417.
31. Huang HC, Jan TR, Yeh SF. Inhibitory effect of curcumin, an antiinflammatoryagent, on vascular smooth muscle cell proliferation. Eur J Pharmacol 1992; 221: 381-384.
32. Ramirez-Bosca A, Soler A, Carrion-Guiterrez MA, Mira DP, Zapata JP, Diaz-Alperi J, Bernd A, Almagro EQ, Miquel J. A hydroalcoholicextract of Curcuma longa lowers the abnormally highvalues of human-plasma fibrinogen. Mech Aging Dev 2000; 114: 207-220.
33. Soni KB, Kuttan R. Effect of administration on oral curcuminserum peroxides and cholesterol levels in human volunteers. IndianJ Physiol Pharmacol 1992; 36: 273-275.
34. Ali HB, Blunden G, Tanira OM, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiberofficinale Roscoe), a review of recent research. Food Chem Toxicol 2008; 46: 409-442.
35. Kemper JK. Ginger (Zingiber officinale), Longwood Herbal TaskForce, Availabe at: http://www.mcp.edu/herbal/default.htm, 1999;pp. 1-18.
36. Afzal M, Al-Hadidi D, Menon M, Pesek J, Dhami MS. Ginger, anethnomedical, chemical and pharmacological review. Drug Metabol. Drug Interact 2001; 18: 159-90.
37. Bordia A, Verma SK, Srivastava KC. Effect of ginger (Zingiberofficinale Roscoe) and fenugreek (Trigonella foenumgraecum L.)on blood lipids, blood sugar and platelet aggregation in patientswith coronary artery disease. Prostaglandins Leukot Essent FattyAcids 1997; 56: 379-384.
38. Sharma I, Gusain D, Dixit VP. Hypolipidaemic and antiatheroscleroticeffects of Zingiber officinale in cholesterol fed rabbits. Phytother Res 1998; 10: 517-518.
39. Bhandari U, Kanojia R, Pillai KK. Effect of ethanolic extractof Zingiber officinale on dyslipidaemia in diabetic rats. J Ethnopharmacol 2005; 97: 227-223.
40. Fuhrman B, Rosenblat M, Hayek T, Coleman R, Aviram M. Gingerextract consumption reduces plasma cholesterol, inhibits ldl oxidationand attenuates development of atherosclerosis in atherosclerotic, apolipoprotein e-deficient mice. J Nutr 2000; 130: 1124-1131.
41. Guh JH, Ko FN, Jong TT, Teng CM. Antiplatelet effects of gingerolisolated from Zingiber officinale. J Pharm Pharmacol 1995; 47: 329-332.
42. Srinivasan K, Sambaiah K. The effect of spices on cholesterol 7alpha-hydroxylase activity and on serum and hepatic cholesterollevels in the rat. Int J Vitam Nutr Res 1991; 61: 363-369.
43. Tanabe M, Chen YD, Saito K, Kano Y. Cholesterol biosynthesisinhibitory component from Zingiber officinable Roscoe. ChemPharm Bull 1993; 41: 710-713.
44. Verma SK, Singh J, Khamesra R, Bordia A. Effect of ginger onplatelet aggregation in man. Indian J Med Res 1993; 98: 240-242.
45. Janssen PL, Meyboom S, Van Staveren WA, Van Staveren WA, De Vegt F, Katan MB. Consumption of ginger (Zingiber officinaleroscoe) does not affect ex vivo platelet thromboxane production inhumans. Eur J Clin Nutr 1996; 50: 772-774.
46. Srinivasan K. Black pepper and its pungent principle - piperine, areview of diverse physiological effects. Crit Rev Food Sci Nutr 2007; 47: 735-748.
47. Wakade SA, Shah SA, Kulkarni PM, Juvekar RA. Protective effectof Piper longum L. on oxidative stressinduced injury and cellularabnormality in adriamycin induced cardiotoxicity in rats. Indian JExp Biol 2008; 46: 528-533.
48. Vijayakumar RS, Surya D, Senthilkumar R, Nalini N. Hypolipidemiceffect of black pepper (Piper nigrum Linn.) in rats fed highfat diet. J Clin Biochem Nutr 2002; 32: 31-42.
49. Shenuarin B, Fukunaga K. Cardioprotection by vanadium compoundstargeting Akt-mediated signaling. J Pharmacol Sci 2009; 110: 1-13.
50. Jayaprakasha GK, Rao LJ, Sakaraiah KK. Volatile constituentsfrom Cinnamomum zeylanicum fruit stalks and their antioxidantactivities. J Agric Food Chem 2003; 51: 4344-4348.
51. Singh G, Maurya S, DeLampasona MP, Catalan CN. A comparisonof chemical, antioxidant and antimicrobial studies of cinnamon leafand bark volatile oils, oleoresins and their constituents. Food ChemToxicol 2007; 45: 1650-1661.
52. Nadkarni KM. Indian Materia Indica; Scientific Publishers: (India)Jodhpur 1976.
53. Warriar PK, Nambiar VPK, Ramankutty C. Indian MedicinalPlants - A Compendium of 500 Species; Vaidyaratnam P. S., Ed, Varier's Arya Vaidyasala: Kottakkal, Kerala, 1994; Vol. 2: pp. 80-83.
54. Wang YS. Pharmacology and Applications of Chinese MateriaMedica. Peoples Health Publishers: Beijing 1983.
55. Bhatacharjee. Hand Book of Indian Medicinal Plants; PointerPublishers: Jaipur 1998.
56. Asolkar LV, Kakkar KK, Chakae OJ. Glossary of Indian MedicinalPlants; Publication and Information Directorate, CSI: New Delhi 1986.
57. Sharma SR, Dwivedi SK, Swarup D. Hypoglycemic and hypolipidemiceffects of Cinnamomum tamala Nees leaves. Indian J ExpBiol 1996; 34: 372-374.
58. Kim NJ, Jung EA, Kim DH, Lee S. Studies on the development ofantihyperlipidemic drugs from Oriental herbal medicine. Korean JPharmacogn 1999; 30: 368-374. 2000; 31: 190-195.
59. Kamal A, Thanaa A, Abd El-Twab M. Oxidative markers, nitricoxide and homocysteine alteration in hypercholesterolimic rats, role of atorvastatine and cinnamon. Int J Clin Exp Med 2009; 2: 254-265.
60. Yadav AS, Bhatnagar D. Modulatory effect of spice extracts oniron-induced lipid peroxidation in rat liver. Biofactors 2007; 29: 147-157.
61. Sheng X, Zhang Y, Gong Z, Huang C, Zang YQ. Improved insulinresistance and lipid metabolism by cinnamon extract through activationof peroxisome proliferator-activated receptors. PPAR Res 2008; 2008: 1-9.
62. Burdock GA, Carabin IG. Safety assessment of coriander (Coriandrumsativum L.) essential oil as a food ingredient. Food ChemToxicol 2009; 47: 22-34.
63. Chithra V, Leelamma S. Hypolipidemic effect of coriander seeds(Coriandrum sativum), mechanism of action. Plant Foods HumNutr 1997; 51: 167-172.
64. Suneetha JW, Krishnakantha TP. Antiplatelet Activity of corianderand curry leaf spices. Pharm Biol 2005; 43: 230-233.
65. Ramadan FM, Amer MMA, Awad A, El-Sayed S. Coriander (Coriandrumsativum L.) seed oil improves plasma lipid profile in ratsfed a diet containing cholesterol. Eur Food Res Technol 2008; 21: 319-328.